KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Shares Issued (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Shares Issued for 8 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 72.18% to $2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2025, down 18.95% year-over-year, with the annual reading at $2.4 million for FY2025, 18.95% down from the prior year.
  • Shares Issued hit $2.3 million in Q4 2025 for Castle Biosciences, up from $77000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $2.5 million in Q3 2021 to a low of -$1.8 million in Q4 2023.
  • Historically, Shares Issued has averaged $523500.0 across 5 years, with a median of $282500.0 in 2022.
  • Biggest YoY gain for Shares Issued was 1046.32% in 2024; the steepest drop was 1241.57% in 2024.
  • Year by year, Shares Issued stood at -$1.6 million in 2021, then soared by 216.77% to $1.8 million in 2022, then crashed by 196.75% to -$1.8 million in 2023, then surged by 176.05% to $1.3 million in 2024, then soared by 72.18% to $2.3 million in 2025.
  • Business Quant data shows Shares Issued for CSTL at $2.3 million in Q4 2025, $77000.0 in Q3 2025, and $19000.0 in Q2 2025.